Device
Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES
Primary PCI of culprit lesion in IRA with drug eluting stent (DES) and PCI of the other critical lesion in IRA with another DES is a medical device with 1 clinical trials. Historical success rate of 100.0%.
Total Trials
1
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Completed(1)
Detailed Status
Completed1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
100.0%
Trials by Status
completed1100%
Recent Activity
0 active trials
Showing 1 of 1
Clinical Trials (1)
Showing 1 of 1 trials
NCT01642784
Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction
All 1 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 1